Pre‐exposure prophylaxis implementation gaps among people vulnerable to HIV acquisition: a cross‐sectional analysis in two communities in western Kenya, 2021–2023.

Autor: Romo, Matthew L., Schluck, Glenna, Kosgei, Josphat, Akoth, Christine, Bor, Rael, Langat, Deborah, Charles, Curtisha, Adjei, Paul, Gayle, Britt, LeeVan, Elyse, Chang, David, Yates, Adam, Yacovone, Margaret, Ake, Julie A., Sawe, Fred, Crowell, Trevor A.

Publikováno v: Journal of the International AIDS Society; Nov2024, Vol. 27 Issue 11, p1-8, 8p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Suboptimal Uptake, Retention, and Adherence of Daily Oral Prexposure Prophylaxis Among People With Opioid Use Disorder Receiving Hepatitis C Virus Treatment.

Autor: Brokus C; DC Partnership for HIV/AIDS Progress, Washington, District of Columbia, USA.; Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, USA., Kattakuzhy S; DC Partnership for HIV/AIDS Progress, Washington, District of Columbia, USA.; Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, USA., Gayle B; DC Partnership for HIV/AIDS Progress, Washington, District of Columbia, USA.; Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, USA., Narayanan S; Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, USA., Davis A; DC Partnership for HIV/AIDS Progress, Washington, District of Columbia, USA.; Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, USA., Cover A; DC Partnership for HIV/AIDS Progress, Washington, District of Columbia, USA.; Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, USA., Eyasu R; DC Partnership for HIV/AIDS Progress, Washington, District of Columbia, USA.; Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, USA., Ebah E; DC Partnership for HIV/AIDS Progress, Washington, District of Columbia, USA.; Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, USA., Ogbumbadiugha-Weekes O; DC Partnership for HIV/AIDS Progress, Washington, District of Columbia, USA.; Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, USA., Hoffmann J; Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, USA., Silk R; DC Partnership for HIV/AIDS Progress, Washington, District of Columbia, USA.; Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, USA., Stevens J; DC Partnership for HIV/AIDS Progress, Washington, District of Columbia, USA.; Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA., Mount J; DC Partnership for HIV/AIDS Progress, Washington, District of Columbia, USA.; Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA., Gannon C; DC Partnership for HIV/AIDS Progress, Washington, District of Columbia, USA.; Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA., Nussdorf L; DC Partnership for HIV/AIDS Progress, Washington, District of Columbia, USA., Mathur P; Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, USA., Bijole P; HIPS, Washington, District of Columbia, USA., Jones M; HIPS, Washington, District of Columbia, USA., Kier R; HIPS, Washington, District of Columbia, USA., Sternberg D; HIPS, Washington, District of Columbia, USA., Greenblatt A; Division of Addiction Research and Treatment, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, Maryland, USA.; Department of Family and Community Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA., Weintraub E; Division of Addiction Research and Treatment, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, Maryland, USA., Masur H; DC Partnership for HIV/AIDS Progress, Washington, District of Columbia, USA.; Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA., Kottilil S; DC Partnership for HIV/AIDS Progress, Washington, District of Columbia, USA.; Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, USA., Rosenthal E; DC Partnership for HIV/AIDS Progress, Washington, District of Columbia, USA.; Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, USA.

Publikováno v: Open forum infectious diseases [Open Forum Infect Dis] 2021 Dec 29; Vol. 9 (3), pp. ofab658. Date of Electronic Publication: 2021 Dec 29 (Print Publication: 2022).